Search results

8 results for Depression in Children and Adolescents

Sorted by Date . Sort by Relevance

  1. Past appeals and decisions

    adalimumab, etanercept & infliximab 31 March 2008 TA010 Asthma (children under 5) - inhaler devices 31 August 2000 TA138 Asthma (in...

  2. Epilepsy

    Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

  3. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  4. Technology appraisal block scoping reports

    This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

  5. Bipolar disorder

    Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

  6. Self-harm

    Everything NICE has said on assessing and managing self-harm in an interactive flowchart

  7. Bipolar disorder: assessment and management (CG185)

    This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.

  8. Antenatal and postnatal mental health: clinical management and service guidance (CG192)

    This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.